Blue Horseshoe Stocks: Multiple Updates

JB Hunt Transport Services, Inc. JBHT

The most interesting options trading candidate we are seeing from the pool of un-traded upon earnings reporters is JBHT, which dropped an extremely solid quarterly in the post-market yesterday. The company beat on earnings, year-over-year revenue, and bested expectations on guidance as well.

We are going to track a pair of contracts, the JBHT Weekly $95-100 Calls to try to take advantage of the resulting activity.
_____

CORRECTION: Reviewing Friday’s Winners:

Yesterday, through a small error, our newsletters went out without the proper figures for our options ideas on Friday. Here are the correct gain totals.

SPDR S&P500 (ETF) SPY Weekly $299-300 Calls
$299 Calls – Range: .67-1.75 – Max Gain: 161%
$299.50 Calls – Range: .34-1.20 – Max Gain: 252%
$300 Calls – Range: .13-.75 – Max Gain: 477%

Cigna Corp. CI Weekly $167.50-175 Calls
$172.50 Calls – Range: 1.26-4.30 – Max Gain: 241%
$175 Calls – Range: 3.70-6.55 – Max Gain: 77%


American Electric Technologies, Inc. AETI

We try to keep running tabs on everything we mention in our daily reports, and in AETI we have a stock that we tagged for observation at the end of May. In the seven ensuing weeks, the stock has more than doubled.

We observed a low of .60 in AETI subsequent to our initial alert and the stock managed to register a new high of 1.45. That works out to an overall rise of 142% and was good for the #2 spot on the NASDAQ gainers list for the day. If it can break previous resistance at 1.61, it will officially be in blue sky territory.


Tautachrome, Inc. TTCM

Our OTC play from yesterday morning was indeed a runner. The stock made an intraday move from a low of .0103-.0197, which marks a 91% gain on what amounted to more than five times the monthly average daily volume.

The extreme volatility here, like the options plays we select, is what makes this attractive to us as short-term traders. We’ll continue to keep an eye on TTCM for any other possible swing trade opportunities.


Taronis Technologies, Inc. TRNX

One we’ve been watching since Monday of last week is TRNX, which was trading for as little as .1832 following our most recent update.

It trended up to and closed at a high of .35 yesterday, and so far in the premarket this morning it has reached as high as .53. That’s an incredible swing of 189% inside of a week! We’ll want to see previous resistance at the 50DMA to hold as support on any pullbacks.


Extended Watchlist:
OSTK, OBLN, MARK, DSS, MLNT, BPTH, NVCR, CGIX

Blue Horseshoe Stocks: Weekly Wrap-Up

Pharma Options Recap

We cast a wide net yesterday with a trio of options ideas in the pharma space related to the reversal of the Trump administration’s position on drug rebate policy. The sector was bustling with activity in the premarket, and two out of our three ideas bore fruit.

Here were the total possible gains available to daytraders for the session:

Cigna Corp. CI $167.50-175 Calls 

$167.50 Calls – Range: 10.04-17.00 – Max Gain: 52%
$170 Calls – Range: 10.02-14.30 – Max Gain: 58%
$175 Calls – Range: 1.10-1.80 – Max Gain: 64%
____

United Health Corp. UNH $250-255 Calls 

$250 Calls – Range: 2.48-11.09 – Max Gain: 52%
$252.50 Calls – Range: 2.50-8.70 – Max Gain: 58%
$255 Calls – Range: .99-6.20 – Max Gain: 70%

In addition to these plays, we’ll continue to keep an eye on the CVS Health Corp. CVS Weekly $57-58.50 Calls  through the end of the day.
____

Fresh Idea:
SPDR S&P500 (ETF) SPY $299-300 Calls


Taronis Technologies, Inc. TRNX

On Monday morning, we highlighted TRNX as a prime bottom-bounce candidate, and we’d like to wrap up the week by going over the solid swings which we subsequently observed in the stock.

On Monday itself, our choice in timing on calling this play was affirmed as we saw a solid 52% run from  .25-.38. This was followed by a pullback to a low of .1832 the following day, and over the course of the rest of the week, TRNX has stair-stepped its way back up to .34, which represents an additional 86% swing.


Extended Watchlist:
MLNT, CLVS, NVCN, APLS, SFIX, ADXS, INFY, OBLN

Blue Horseshoe Stocks: Pharma News

Pharma News Drives Sector

Somewhat of a reversal of fortunes has befallen major healthcare middlemen this week, and for them it’s good news. The Trump administration is doing a 180° on proposed changes to drug rebates that would have cost the healthcare industry.

The development is causing healthcare stocks to rise here in the premarket, and a few that have caught our eye in particular, are UNH, CI, and CVS. Each of these plays is flying high in early trading, so what we’re going to look for is a classic dip-and-rip scenario. Profit-taking right out of the starting gate should drive these stocks down off of their lofty premarket highs, and that’s when where we come in with the following ideas.

CVS Health Corp. CVS Weekly $57-58.50 Calls
Cigna Corp. CI $167.50-175 Calls
United Health Corp. UNH $250-255 Calls 


Extended Watchlist:
PCG, NAVB, TRNX, OMER, ATOS, HTGM, DPLO, KBLB

Blue Horseshoe Stocks: Fresh Bottom Plays

New Bottom Plays

While we are in a bit of a drought in terms of big name earnings reports, as tends to happen around a holiday. We’re back for a full, fresh trading week and we thought we’d shift our focus to bottom plays as we kick things off. 

Taronis Technologies, Inc. TRNX

TRNX is in precisely the sort of position in which we look for bottom-bounce candidates. The stock saw new lows last week before making its reversal, and stringing together three consecutive positive sessions.

We can also see on the RSI that TRNX is just now coming off of being extremely oversold and the volatility potential suggests that even a 100% move from current pricing would not be out of the realm of possibility. We’ll be keeping an eye peeled here in the days and weeks ahead.

______

Rockwell Medical Technologies, Inc. RMTI 

RMTI is another possible bottom play with some decent potential and a gap to fill the 200DMA currently sitting at 4.11. Perhaps the upside potential here is not quite of the magnitude of the previously mentioned play, but the indicators may be more ripe in this case.

The MACD is on the precipice of a bullish cross, and the RSI is slowly attempting to come off of being oversold. This may also be a good candidate for a more sustained recovery over the next several sessions.


Extended Watchlist:
TBRG, LPTX, GROW, NAKD, DPW, ITCI